NASDAQ · Medical - Equipment & Services

MMED (MMED) Stock

$17.64 -0.17% NASDAQ: MMED Healthcare

Valuation

MetricValue
Price$17.64
Market Cap$4.95B
P/E Ratio-14.85
P/B Ratio1.21
P/S Ratio1.95
EPS (TTM)$-0.89
52-Week High$20.48
52-Week Low$10.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.45%
ROA-11.04%
ROCE-5.47%
Gross Margin52.91%
Operating Margin-9.15%
Net Margin-21.74%
Debt/Equity0.04
Current Ratio1.92

Annual Financials (USD)

Metric2022202320242025
Revenue$2.2B$2.5B$2.7B$3.1B
Operating Profit$-69.0M$-69.0M$-202.0M$49.0M
Net Profit$-96.0M$-112.0M$-250.0M$-331.0M
EPS$-0.34$-0.40$-0.89$-1.29
Op Margin-3.1%-2.8%-7.4%1.6%

Balance Sheet (USD)

Metric2022202320242025
Total Assets—$4.1B$4.2B$4.6B
Total Liabilities—$646.0M$870.0M$1.0B
Cash—$54.0M$11.0M$298.0M
Borrowings$0$8.0M$11.0M$145.0M

Latest News

MiniMed Flex™ Now Available to Medicare and Medicare Advantage Beneficiaries PR Newswire · Jul 22, 2026 MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results PR Newswire · Jul 20, 2026 MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors PR Newswire · Jun 29, 2026 This Undervalued Medical-Devices Stock Is Poised for a Rebound Barrons.com · Jun 22, 2026 MiniMed Launches Flex Insulin Pump in US MT Newswires · Jun 17, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-6.0M$41.0M$140.0M$-197.0M
Investing Cash Flow$-347.0M$-305.0M$-386.0M$-456.0M
Financing Cash Flow$185.0M$112.0M$10.0M$178.0M
Net Cash Flow$-2.0M$-4.0M$-43.0M$287.0M
Free Cash Flow$-173.0M$-107.0M$-53.0M$-420.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.15
EV / EBITDA201.51
FCF Yield-4.08%
Quick Ratio1.43
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held90.75%
Institutions Held12.28%
Institutions Float Held132.70%
Institutional HolderSharesReport Date
Massachusetts Financial Services Co.6,878,4602026-03-31
Longaeva Partners L.P.3,178,6542026-03-31
Citadel Advisors Llc2,851,5392026-03-31
Millennium Management Llc2,593,4342026-03-31
Alyeska Investment Group, L.p.2,000,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About MMED

MMED is headquartered in US.

MMED stock trades at $17.64 with a market capitalization of $4.95B. The stock is valued at a price-to-earnings (P/E) ratio of -14.85, price-to-book of 1.21, price-to-sales of 1.95. Over the past 52 weeks the stock has ranged between $10.65 and $20.48, and currently trades 13.9% below its 52-week high.

On profitability, MMED generates a return on equity (ROE) of -14.45%, return on capital employed of -5.47%, an operating margin of -9.15%, a net profit margin of -21.74%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides